Harnessing the power of Microglia to improve the lives of patients, caregivers and families through transformative treatments for neurodegenerative diseases. Vigil Neuroscience is the world’s first microglia-focused therapeutics company. With a purpose to treat rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain’s immune system. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.